• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症对恶性胆道梗阻患者自膨式金属支架置入后复发性胆道梗阻的影响。

Impact of sarcopenia on recurrent biliary obstruction after insertion of self-expandable metallic stent in patients with malignant biliary obstruction.

机构信息

Third Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Department of Endoscopy, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

J Hepatobiliary Pancreat Sci. 2021 Jul;28(7):572-580. doi: 10.1002/jhbp.970. Epub 2021 May 12.

DOI:10.1002/jhbp.970
PMID:33905608
Abstract

BACKGROUND/PURPOSE: Recurrent biliary obstruction (RBO) after self-expandable metallic stent (SEMS) insertion is a big problem in patients with unresectable malignant biliary obstruction (MBO). Sarcopenia is associated with poor prognosis in patients with malignancies. The purpose of this study is to clarify the relationship between RBO and sarcopenia.

METHODS

Forty-six patients with normal psoas muscle mass index (PMI) and 55 with low PMI were enrolled, based on PMI cut-off values. We analyzed the cumulative incidences and predictors of RBO, considering death without RBO to be a competing risk.

RESULTS

In the Kaplan-Meier analysis, the 60-, 180-, and 360-day cumulative incidence rates of RBO were 0.0%, 12.2%, and 22.0% in the normal PMI group, as compared to 4.0%, 31.1%, and 55.0% in the low PMI group, respectively (log-rank P = .003). In competing risk analysis, the incidences were 2.9%, 2.9%, and 7.1% in the normal PMI group, as compared to 13.7%, 34.8%, and 51.7% in the low PMI group, respectively (P < .001). In multivariate Cox regression and Fine-Gray's analyses, hazard ratios of low PMI for RBO were 4.593 (95% confidence interval 1.673-12.61, P = .003) and 4.980 (2.045-12.13, P < .001), respectively.

CONCLUSIONS

Sarcopenia in MBO was an independent risk factor for RBO.

摘要

背景/目的:不可切除恶性胆道梗阻(MBO)患者自膨式金属支架(SEMS)置入后出现复发性胆道梗阻(RBO)是一个大问题。肌肉减少症与恶性肿瘤患者的预后不良有关。本研究旨在阐明 RBO 与肌肉减少症之间的关系。

方法

根据肌肉减少症指数(PMI)截断值,纳入 46 例 PMI 正常和 55 例 PMI 降低的患者。我们分析了 RBO 的累积发生率和预测因素,考虑到无 RBO 死亡是一个竞争风险。

结果

在 Kaplan-Meier 分析中,正常 PMI 组的 60、180 和 360 天 RBO 累积发生率分别为 0.0%、12.2%和 22.0%,而低 PMI 组分别为 4.0%、31.1%和 55.0%(对数秩 P = 0.003)。在竞争风险分析中,正常 PMI 组的发生率分别为 2.9%、2.9%和 7.1%,低 PMI 组分别为 13.7%、34.8%和 51.7%(P < 0.001)。在多变量 Cox 回归和 Fine-Gray 分析中,低 PMI 发生 RBO 的风险比分别为 4.593(95%置信区间 1.673-12.61,P = 0.003)和 4.980(2.045-12.13,P < 0.001)。

结论

MBO 中的肌肉减少症是 RBO 的独立危险因素。

相似文献

1
Impact of sarcopenia on recurrent biliary obstruction after insertion of self-expandable metallic stent in patients with malignant biliary obstruction.肌肉减少症对恶性胆道梗阻患者自膨式金属支架置入后复发性胆道梗阻的影响。
J Hepatobiliary Pancreat Sci. 2021 Jul;28(7):572-580. doi: 10.1002/jhbp.970. Epub 2021 May 12.
2
Impact of sarcopenia on recurrent biliary obstruction after EUS-guided biliary drainage in patients with malignant biliary obstruction.肌肉减少症对恶性胆管梗阻患者内镜超声引导下胆管引流术后复发性胆管梗阻的影响。
Int J Clin Oncol. 2024 Mar;29(3):286-296. doi: 10.1007/s10147-023-02455-2. Epub 2024 Jan 27.
3
Predictors of Recurrent Biliary Obstruction Following Percutaneous Uncovered Metal Stent Insertion in Patients with Distal Malignant Biliary Obstruction: An Analysis Using a Competing Risk Model.远端恶性胆管梗阻患者经皮置入裸金属支架后复发性胆管梗阻的预测因素:一项使用竞争风险模型的分析
Cardiovasc Intervent Radiol. 2019 Feb;42(2):276-282. doi: 10.1007/s00270-018-2107-9. Epub 2018 Nov 8.
4
Efficacy of multi-hole self-expandable metal stent compared to fully covered and uncovered self-expandable metal stents in patients with unresectable malignant distal biliary obstruction: a propensity analysis.多孔自膨式金属支架与全覆膜和无覆膜自膨式金属支架治疗不可切除性恶性远端胆管梗阻患者的疗效比较:一项倾向分析
Surg Endosc. 2024 Jan;38(1):212-221. doi: 10.1007/s00464-023-10541-9. Epub 2023 Nov 14.
5
Reintervention for stent occlusion after bilateral self-expandable metallic stent placement for malignant hilar biliary obstruction.双侧自膨式金属支架置入治疗恶性肝门部胆管梗阻后支架闭塞的再次干预
Dig Endosc. 2016 Nov;28(7):731-737. doi: 10.1111/den.12657. Epub 2016 Apr 21.
6
Risk factors for recurrent biliary obstruction following endoscopic biliary stenting in patients with unresectable ampullary cancer: A multicenter retrospective study.无法切除的壶腹周围癌患者内镜下胆管支架置入术后复发性胆道梗阻的危险因素:一项多中心回顾性研究。
J Dig Dis. 2024 May;25(5):310-317. doi: 10.1111/1751-2980.13288. Epub 2024 Jun 20.
7
Covered duodenal self-expandable metal stents prolong biliary stent patency in double stenting: The largest series of bilioduodenal obstruction.覆膜十二指肠自膨式金属支架延长双支架胆道通畅:最大系列的胆肠吻合口梗阻。
J Gastroenterol Hepatol. 2018 Mar;33(3):696-703. doi: 10.1111/jgh.13977.
8
Pilot study of a novel, large-bore, fully covered self-expandable metallic stent for unresectable distal biliary malignancies.一种新型大口径全覆膜自膨式金属支架用于不可切除远端胆管恶性肿瘤的初步研究。
Dig Endosc. 2016 Sep;28(6):671-9. doi: 10.1111/den.12643. Epub 2016 Jun 6.
9
Estimation and comparison of cumulative incidences of biliary self-expandable metallic stent dysfunction accounting for competing risks.考虑竞争风险的胆道自膨式金属支架功能障碍累积发生率的估计与比较
Dig Endosc. 2014 Mar;26(2):270-5. doi: 10.1111/den.12120. Epub 2013 May 8.
10
Angle of covered self-expandable metallic stents after placement is a risk factor for recurrent biliary obstruction.置入后带膜自膨式金属支架的角度是复发性胆管梗阻的一个危险因素。
World J Hepatol. 2022 May 27;14(5):992-1005. doi: 10.4254/wjh.v14.i5.992.

引用本文的文献

1
Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospective study.肌肉减少症及骨骼肌质量变化对接受一线吉西他滨和纳米紫杉醇化疗的胰腺导管腺癌患者预后的影响:一项前瞻性研究
J Gastroenterol. 2025 Jul 17. doi: 10.1007/s00535-025-02283-3.
2
Skeletal muscle status and survival among patients with advanced biliary tract cancer.晚期胆道癌患者的骨骼肌状况与生存。
Int J Clin Oncol. 2024 Mar;29(3):297-308. doi: 10.1007/s10147-023-02466-z. Epub 2024 Feb 6.
3
Endeavors to prevent stent malfunction: new insights into the risk factors for recurrent biliary obstruction.
预防支架功能障碍的努力:对复发性胆管梗阻危险因素的新见解。
Clin Endosc. 2024 Jan;57(1):56-57. doi: 10.5946/ce.2023.274. Epub 2024 Jan 26.
4
Impact of sarcopenia on recurrent biliary obstruction after EUS-guided biliary drainage in patients with malignant biliary obstruction.肌肉减少症对恶性胆管梗阻患者内镜超声引导下胆管引流术后复发性胆管梗阻的影响。
Int J Clin Oncol. 2024 Mar;29(3):286-296. doi: 10.1007/s10147-023-02455-2. Epub 2024 Jan 27.
5
Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer.肌肉减少症对胰腺癌新辅助治疗期间胆汁引流的影响。
Clin Endosc. 2024 Jan;57(1):112-121. doi: 10.5946/ce.2022.278. Epub 2023 Jul 18.